Enrich Therapeutics established in July 2018 and develops novel single live cell isolation platform, different from existing flow/fluidics based technologies, our platform can work on adherent cells as well as all nonideal cell samples, i.e. partially digested, clumpy or less plentiful samples.
Enrich technology aims to provide game-changing life science tool to global single cell researchers for significant improvement of scalability and affordability in many applications, such as T-cell therapy development, antibody-drug discovery, NGS, etc. We can help global biomedical researchers capturing meaningful clones to accelerate discovery!
Our patented LASUM (LCD aided selection under microscope) technology uses a software approach to increase the accuracy of pinpointing the location of the cell instead of the high-cost hardware setup. The procedure to isolating the single cell is easy to carry out on the benchtop and the viability of the cell remains very high during the sorting process. As long as you can see the desired cell under the microscope, we can always capture it!
Please fill out the contact form to obtain more information!